LIVE Webinar

Tuesday, November 23, 2021
2:30 - 4:00 PM Eastern Time

Register Now

Scientists have made great strides to improve cellular models that permit high-throughput screens to identify and characterize therapeutic candidates. For example, researchers now derive cardiomyocytes from human pluripotent stem cells (PSCs) to study a compound’s effect on cardiac function. To guarantee the experimental success and reproducibility of PSC-based high-throughput screens, researchers must apply good PSC culturing practices, ensure consistent and efficient differentiation, and incorporate quality controls at various steps. In this webinar, brought to you by Miltenyi Biotec, experts will present a complete workflow to perform high-throughput screens with PSC-derived cardiomyocytes.

Topics to be covered

  • The importance of high-quality PSC lines
  • How to control PSC differentiation
  • Incorporating reliable quality control steps

Register Now

Meet the Speakers:

Viola Stella Palladino, PhD
Group Leader
Regenerative Medicine
Miltenyi Biotec

Laura M. Müller, PhD
Product Manager
Flow Cytometry Reagents
Miltenyi...


Sponsored By

Interested in reading more?

800x560-nov-23-2021

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!